US Broker Ratings

Revolution Medicines, Inc. (RVMD) Stock Analysis: Promising RAS-Targeted Therapies and a 5.37% Upside

Revolution Medicines, Inc. (NASDAQ: RVMD) has been making waves in the biotechnology sector with its innovative approach to treating RAS-addicted cancers. As a clinical-stage precision oncology company, Revolution Medicines is..

Oscar Health, Inc. (OSCR) Stock Analysis: Navigating a Challenging Market with a 23.2% Revenue Growth

Oscar Health, Inc. (NYSE: OSCR) is making waves in the healthcare sector with a robust revenue growth of 23.2%. As a healthcare technology company, Oscar Health provides innovative health plans..

Molina Healthcare Inc (MOH) Stock Analysis: Navigating Growth and Valuation Challenges

Molina Healthcare Inc (NYSE: MOH), a prominent player in the healthcare plans sector, has been a focal point of investor interest due to its involvement in managed healthcare services for..

iRhythm Technologies, Inc. (IRTC) Stock Analysis: A 24.76% Potential Upside with Strong Buy Ratings

iRhythm Technologies, Inc. (IRTC), a leading player in the healthcare sector specializing in medical devices, is attracting significant investor attention due to its innovative cardiac monitoring solutions and promising market..

Option Care Health, Inc. (OPCH) Stock Analysis: A 13% Upside Potential Amid Robust Healthcare Growth

Option Care Health, Inc. (NASDAQ: OPCH) has positioned itself as a formidable player within the healthcare sector, specifically in the medical care facilities industry. Headquartered in Bannockburn, Illinois, the company..

STERIS plc (STE) Stock Analysis: Exploring a 12.63% Upside Potential in the Healthcare Sector

Investors looking to delve into the healthcare sector’s promising opportunities might find STERIS plc (NYSE: STE) a compelling candidate. With a market capitalization of $24.63 billion, STERIS is a significant..

IDEXX Laboratories, Inc. (IDXX) Stock Analysis: Revenue Growth Shines Amid Volatile Market

IDEXX Laboratories, Inc. (NASDAQ: IDXX) stands as a formidable player in the Healthcare sector, specifically within the Diagnostics & Research industry. With a substantial market capitalization of $53.6 billion, the..

RadNet, Inc. (RDNT): Investor Outlook on a 29% Upside Potential in Diagnostics & Research

RadNet, Inc. (NASDAQ: RDNT), a key player in the healthcare sector, stands out with its robust potential for growth in the diagnostics and research industry. Based in the United States,..

Grifols, S.A. (GRFS) Stock Analysis: Exploring a 20% Upside Potential and Solid Dividend Yield

Grifols, S.A. (NASDAQ: GRFS), a key player in the healthcare sector, is drawing investor attention with its potential for a 20.13% upside, according to analyst consensus. The Spanish drug manufacturer,..

Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: Exploring a 27.41% Potential Upside in the Healthcare Sector

Prestige Consumer Healthcare Inc. (NYSE: PBH) is an intriguing player in the healthcare sector, specializing in over-the-counter (OTC) health and personal care products. With a market capitalization of $3.01 billion,..

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: Evaluating a 50% Upside Potential Amidst Biotech Innovations

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) stands at a pivotal junction in the biotechnology sector, boasting a market capitalization of $11.42 billion. As a leader in the development and commercialization of..

Elanco Animal Health (ELAN) Stock Analysis: Exploring a 11% Potential Upside for Investors

Elanco Animal Health Incorporated (NYSE: ELAN) stands out as a major player in the healthcare sector, specifically within the niche of specialty and generic drug manufacturing for animals. Based in..

Novo Nordisk A/S (NVO) Stock Analysis: Evaluating the 71.47% Return on Equity in the Healthcare Sector

Novo Nordisk A/S (NYSE: NVO), a dominant force in the healthcare sector, stands out not only for its impressive market capitalization of $232.79 billion but also for a remarkable return..

Telix Pharmaceuticals Limited (TLX) Stock Analysis: Unveiling a 180% Potential Upside in Radiopharmaceutical Innovation

Investors seeking opportunities in the biotechnology sector might find Telix Pharmaceuticals Limited (ASX: TLX) an intriguing prospect. With a focus on the development and commercialization of diagnostic and therapeutic radiopharmaceuticals,..

United Therapeutics Corporation (UTHR) Stock Analysis: A Healthcare Giant with Strong Growth Potential and Robust Analyst Support

United Therapeutics Corporation (NASDAQ: UTHR) stands out in the healthcare sector, particularly within the specialized and generic drug manufacturing industry. With a market capitalization of $22.46 billion, this biotech company..

Hologic, Inc. (HOLX) Stock Analysis: Evaluating the 2.6% Potential Upside Amid Strong Revenue Growth

Hologic, Inc. (NASDAQ: HOLX), a prominent player in the healthcare sector with a focus on medical instruments and supplies, presents an intriguing opportunity for investors. With a market capitalization of..

Legend Biotech Corporation (LEGN) Stock Analysis: Exploring a Potential 235% Upside in the Booming Biotech Sector

Legend Biotech Corporation (NASDAQ: LEGN), a promising player in the biopharmaceutical landscape, is capturing attention with its groundbreaking work in cell therapies aimed at treating cancer. With a market capitalization..

ADMA Biologics (ADMA): Analyst Consensus Points to a 43.55% Upside Potential in Biotech

ADMA Biologics Inc (NASDAQ: ADMA) stands out in the biotech sector with a significant promise of growth and development. Founded in 2004 and headquartered in Ramsey, New Jersey, ADMA is..

Incyte Corporation (INCY): Stock Analysis Highlights Strong Revenue Growth and Robust Pipeline

Incyte Corporation (NASDAQ: INCY), a notable player in the biotechnology sector, has been making waves with its impressive revenue growth and promising drug pipeline. With a market capitalization of $19.91..

Natera, Inc. (NTRA) Investor Outlook: Exploring a $31.91 Billion Market Cap and 8.53% Potential Upside

Natera, Inc. (NASDAQ: NTRA), a prominent player in the healthcare sector, specifically within diagnostics and research, has captured investor attention with its dynamic approach to molecular testing services. Headquartered in..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds